首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   215篇
  免费   6篇
  国内免费   38篇
儿科学   10篇
妇产科学   1篇
基础医学   24篇
临床医学   31篇
内科学   40篇
皮肤病学   1篇
神经病学   4篇
特种医学   99篇
外科学   11篇
综合类   12篇
预防医学   7篇
药学   17篇
肿瘤学   2篇
  2020年   1篇
  2016年   1篇
  2015年   4篇
  2014年   6篇
  2013年   8篇
  2012年   3篇
  2011年   2篇
  2010年   4篇
  2009年   7篇
  2008年   2篇
  2007年   27篇
  2006年   4篇
  2005年   11篇
  2004年   2篇
  2003年   1篇
  2002年   1篇
  2001年   3篇
  2000年   5篇
  1999年   1篇
  1998年   14篇
  1997年   8篇
  1996年   10篇
  1995年   15篇
  1994年   7篇
  1993年   11篇
  1992年   3篇
  1991年   3篇
  1990年   9篇
  1989年   18篇
  1988年   9篇
  1987年   10篇
  1986年   8篇
  1985年   6篇
  1984年   3篇
  1983年   5篇
  1982年   4篇
  1981年   8篇
  1980年   3篇
  1979年   1篇
  1978年   2篇
  1977年   4篇
  1976年   3篇
  1975年   2篇
排序方式: 共有259条查询结果,搜索用时 15 毫秒
61.
Hereditary spherocytosis (HS) is a common hemolytic anemia of variable clinical expression. Pathogenesis of HS has been associated with defects of several red cell membrane proteins including erythroid band 3. We have studied erythrocyte membrane proteins in 166 families with autosomal dominant HS. We have detected relative deficiency of band 3 in 38 kindred (23%). Band 3 deficiency was invariably associated with mild autosomal dominant spherocytosis and with the presence of pincered red cells in the peripheral blood smears of unsplenectomized patients. We hypothesized that this phenotype is caused by band 3 gene defects. Therefore, we screened band 3 DNA from these 38 kindred for single strand conformational polymorphisms (SSCP). In addition to five mutations detected previously by SSCP screening of cDNA, we detected 13 new band 3 gene mutations in 14 kindred coinherited with HS. These novel mutations consisted of two distinct subsets. The first subset included seven nonsense and frameshift mutations that were all associated with the absence of the mutant mRNA allele from reticulocyte RNA, implicating decreased production and/or stability of mutant mRNA as the cause of decreased band 3 synthesis. The second group included five substitutions of highly conserved amino acids and one in-frame deletion. These six mutations were associated with the presence of comparable levels of normal and mutant band 3 mRNA. We suggest that these mutations interfere with band 3 biosynthesis leading thus to the decreased accumulation of the mutant band 3 allele in the plasma membrane.  相似文献   
62.
IgG-HD37-SMPT-dgA is a deglycosylated ricin A chain (dgA)-containing immunotoxin (IT) prepared by conjugating the monoclonal murine (MoAb) anti-CD19 antibody, HD37, to dgA using the heterobifunctional hindered disulfide linker, N-succinimidyl-oxycarbonyl-alpha-methyl-alpha-(2- pyridyldithio) toluene (SMPT). In this report, we have used two regimens for the administration of IgG-HD37-SMPT-dgA to patients with non-Hodgkin's lymphoma (NHL) in two concomitant phase I trials. One trial examined four intermittent bolus infusions administered at 48- hour intervals. The other studied a continuous infusion (CI) administered over the same 8-day period. In the intermittent bolus regimen, the maximum tolerated dose (MTD) was 16 mg/m2/8 d and the dose- limiting toxicity (DLT) consisted of vascular leak syndrome (VLS), aphasia, and evidence of rhabdomyolysis encountered at 24 mg/m2/8 d. Using the CI regimen, the MTD was defined by VLS at 19.2 mg/m2/8 d. At the MTD of both regimens, a novel toxicity, consisting of acrocyanosis with reversible superficial distal digital skin necrosis in the absence of overt evidence of systemic vasculitis, occurred in 3 patients. Of 23 evaluable patients on the bolus schedule, there was 1 persisting complete response (CR; > 40 months) and 1 partial response (PR). Of 9 evaluable patients on the continuous infusion regimen, there was 1 PR. Pharmacokinetic parameters for the bolus regimen at the MTD showed a mean maximum serum concentration (Cmax) of 1,209 +/- 430 ng/mL, with a median T1/2 beta for all courses of 18.2 hours (range, 10.0 to 80.0 hours), a volume of distribution (Vd) of 10.9 L (range, 3.1 to 34.5 L), and a clearance (CL) of 0.45 L/h (range, 0.13 to 2.3 L/h). For the CI regimen at MTD, the mean Cmax was 963 +/- 473 ng/mL, with a median T1/2 beta for all courses of 22.8 hours (range, 24.1 to 30.6 hours), a Vd of 9.4 L (range, 4.4 to 19.5 L), and a CL of 0.32 L/h (range, 0.12 to 0.55 L/h). Twenty-five percent of the patients on the bolus infusion regimen and 30% on the CI regimen made antibody against mouse Ig (HAMA) and/or ricin A chain antibody (HARA). We conclude that this IT can be administered safely and that both regimens achieve comparable peak serum concentrations at the MTD; these concentrations are similar to those achieved previously using other regimens with IgG-dgA ITs at their respective MTDs. Thus, toxicity is related to the serum level of the IT and does not differ with different targeting MoAbs.  相似文献   
63.
Ratnoff  WD; Gress  RE 《Blood》1980,56(2):233-236
The occurrence of polycythemia vera in a father and son, both of whom had intermittent exposure to organic solvents, including tetrachloroethylene and Stoddard solvent, is reported. Only three other well substantiated familial occurrences of polycythemia vera, none encompassing successive generations, were found among many reported instances.  相似文献   
64.
65.
涤纶补片在颈动脉内膜剥脱术中的常规应用   总被引:1,自引:0,他引:1  
目的:颈动脉内膜剥脱术是防治颅外颈动脉硬化生度狭窄致缺血性脑中风的标准方法,如何预防术后颈动态再狭窄的发生是该手术的关键。本拟对术中常规应用Hema Carotid涤纶补片对内膜剥脱后颈动脉行成形关闭作一些探讨。方法:将58例德国患行标准的颈动脉内膜剥脱术,对术中及术后近期并发症作一总结。结果:围手术期患死亡率及中风率是0%,术后发生一过性脑缺血的患人数是2例(3.45%),但未发现急性颈动脉闭塞,与手术操作有关的并发症是2例(3.45%)。结论:术中常规应用涤纶补片是颈动脉内膜剥脱术手术成功防止术后颈动脉再狭窄的关键步骤,对于国内开展该手术有一定借鉴。  相似文献   
66.
It is discussed whether capsaicin, an agonist of the pain mediating TRPV1 receptor, decreases or increases voltage-activated calcium channel (VACC) currents (I(Ca(V))). I(Ca(V)) were isolated in cultured dorsal root ganglion (DRG) neurones of rats using the whole cell patch clamp method and Ba2+ as charge carrier. In large diameter neurones (>35 micorm), a concentration of 50 microM was needed to reduce I(Ca(V)) (activated by depolarizations to 0 mV) by 80%, while in small diameter neurones (< or =30 microm), the IC50 was 0.36 microM. This effect was concentration dependent with a threshold below 0.025 microM and maximal blockade (>80%) at 5 microM. The current-voltage relation was shifted to the hyperpolarized direction with an increase of the current between -40 and -10 mV and a decrease between 0 and +50 mV. Isolation of L-, N-, and T-type calcium channels resulted in differential effects when 0.1 microM capsaicin was applied. While T-type channel currents were equally reduced over the voltage range, L-type channel currents were additionally shifted to the hyperpolarized direction by 10 to 20 mV. N-type channel currents expressed either a shift (3 cells) or a reduction of the current (4 cells) or both (3 cells). Thus, capsaicin increases I(Ca(V)) at negative and decreases I(Ca(V)) at positive voltages by differentially affecting L-, N-, and T-type calcium channels. These effects of capsaicin on different VACCs in small DRG neurones, which most likely express the TRPV1 receptor, may represent another mechanism of action of the pungent substance capsaicin in addition to opening of TRPV1.  相似文献   
67.
68.
69.
Graeb  DA; Steinbok  P; Robertson  WD 《Radiology》1982,144(4):813-817
Transient computed tomographic (CT) changes occurring within three months after radiotherapy are described in three patients with cerebral gliomas. These changes consist of enlargement of an area of central necrosis, new tumor enhancement, and increased tumor enhancement with adjacent low-density changes. Subsequent scans showed regression of these changes in all patients. It is proposed that these changes are the direct effect of radiation on tumor tissue and adjacent normal brain; possible mechanisms are discussed. These radiation-induced changes mimic tumor progression on CT. The importance of recognizing their transient nature is stressed.  相似文献   
70.
Ultrasonic visualization of the pancreatic duct   总被引:1,自引:0,他引:1  
  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号